Spurred by the opioid crisis, Illinois expanded its medical marijuana program to make it easier for patients to obtain registration cards, and to allow patients suffering from conditions that have traditionally been treated with opioids to obtain medical cannabis as an alternative.
This week, Illinois Governor Bruce Rauner—who is generally thought to be hostile to the state’s medical marijuana program—signed into law the Alternative to Opioids Act of 2018. This legislation eliminates the requirement that patients and caregivers undergo a criminal background and fingerprint check in order to obtain registration cards, as well as the prior rule that disqualified patients who had been convicted of certain criminal offenses.
The legislation also creates a new category of patient who can obtain medical cannabis. The list of about 40 debilitating conditions for which medical cannabis is allowed remains in effect. Under the new legislation, patients who suffer from “a medical condition for which an opioid has been or could be prescribed by a physician based on generally accepted standards of care” can participate in the Opioid Alternative Pilot Program. Opioid patients must be 21 years or older, and are entitled to 2.5 ounces of cannabis per 14-day period.
The new law makes a number of other important changes. Patients may now obtain a “provisional registration” that will allow a patient to purchase medical cannabis while awaiting the state’s decision on registration. It also permits certifying physicians to notify regulators if a registered patient no longer suffers from a debilitating condition, if the bona fide physician-patient relationship was terminated, or if the patient’s continued use of medical cannabis would result in contraindication with the patient’s other medication. In addition, this week’s legislation makes it a misdemeanor to charge a fee for assisting a patient with a medical cannabis application.
Illinois’ medical cannabis program is still technically a pilot program, and is still slated to expire on June 30, 2020. And while the new laws go into effect immediately, from a practical perspective, there will be no changes until regulators determine the rules to implement the new law. Nevertheless, the Alternative to Opioids Act could prove to be a game changer for Illinois’ medical cannabis industry, which is still struggling in many ways.
Mike has a unique ability to stay focused and even-keeled even when it may look to some like the sky is falling. He takes a thoughtful and direct approach to advising clients in the areas of aviation and aerospace law, commercial ...
Welcome to the Cannabis Business Legal News blog where attorneys from Amundsen Davis blog about all things cannabis business and legal news related.
- The Federal Government & CBD – What the FDA is Happening?
- Illinois Lawmaker Introduces Legislation to Legalize Psychedelic Therapy Programs
- Illinois Set to Roll out New Cannabis Retail License Applications and Lottery in Early 2023
- Could a Small Town in Pennsylvania Force Congress to Deschedule Cannabis?
- No April Fool’s Joke: The MORE Act was Just Passed by the House
- Significant Increase in Production of Cannabis and Psychedelics for Research Proposed by the DEA for 2022 – What You Need to Know Now
- Protecting Your Cannabis Business from the Trappings of the Telephone Consumer Protection Act
- The Historic Cannabis Administration and Opportunity Act Could Finally End Federal Cannabis Prohibition
- Illinois Cannabis Market Poised to Take Off With New Dispensary Lottery Bill and Issuance of New Licenses for Craft Growers, Infusers, and Transporters
- Federal Cannabis Reform Gaining Momentum: New Legalization Bill Introduced by Republican Congressmen